| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 3 | 0 | 0 | 0 | 2 |
| Expenses | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 4 | 0 | 1 | 57 | 57 |
| EBITDA | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | -1 | -0 | -1 | -57 | -55 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | -1 % | 0 % | 0 % | 4 % | -53 % | 0 % | 0 % | 0 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | -0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 | -57 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 | -57 |
| EPS in ₹ | -0.01 | -0.03 | -0.02 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | -1.01 | -1.00 |
Johnson Pharmacare
Johnson Pharmacare
0.47
0.00
(0.00%)
Market Cap
25.90 Cr
PE Ratio
-0.46
Volume
6,13,711.00
Day High - Low
0.47 - 0.46
52W High-Low
0.85 - 0.45
Key Fundamentals
Market Cap
25.90 Cr
EPS
-1.01
PE Ratio
-0.46
PB Ratio
58.75
Book Value
0.01
EBITDA
-57.05
Dividend Yield
0.00 %
Industry
Commercial Services Sector
Diversified Services Return on Equity
-1.04
Debt to Equity
0.02
Actual
Company News
View All News
Johnson Pharmacare Q1FY27 Loss Widens
8 days ago
8 days agoJohnson Pharmacare Ltd reported a widened standalone net loss of ₹110.31 lakh for Q1FY27, up from ₹5.34 lakh in the same period last year, with no operating income recorded.
Johnson Pharmacare FY26 loss widensJun 19, 2026
Jun 19, 2026Johnson Pharmacare reported a net loss of ₹5,573.39 lakh for FY26. The auditor flagged non-compliance with Ind AS and internal control gaps.
Johnson Pharmacare CS resignsJun 12, 2026
Jun 12, 2026Johnson Pharmacare Ltd accepts Neha Srivastava's resignation as Company Secretary effective June 11, 2026, due to personal reasons.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
340.60 | #1 14,719.36 | 23.80 | 1,661.90 | 52.68 | #1 711 | 30.99 | 44.49 | |
682.90 | 9,464.33 | 112.29 | 2,440.18 | 20.56 | 53 | 70.92 | 40.53 | |
1,035.80 | 7,298.24 | 17.43 | 1,037.50 | 20.00 | 413 | 4.06 | 41.20 | |
523.25 | 5,978.76 | 209.71 | 1,795.81 | 27.39 | 5 | 411.90 | 68.09 | |
25.58 | 5,945.77 | #1 12.28 | 833.38 | #1 1,66,576.00 | 174 | #1 7,933.33 | 38.76 | |
417.75 | 5,902.84 | 39.77 | #1 16,030.10 | 20.92 | 138 | 9.47 | 42.18 | |
624.75 | 5,630.12 | 15.92 | 683.30 | 5.94 | 346 | 18.84 | 51.01 | |
335.85 | 5,016.25 | 19.80 | 15,321.70 | 2.21 | 222 | 60.98 | 63.06 | |
247.00 | 4,066.55 | 14.02 | 2,487.18 | 0.48 | 293 | -10.58 | 36.86 | |
189.10 | 4,008.88 | -42.89 | 1,527.50 | 38.50 | -106 | 35.05 | 61.87 |
Growth Rate
Revenue Growth
-
Net Income Growth
9,188.33 %
Cash Flow Change
-3,720.00 %
ROE
197.14 %
ROCE
212.12 %
EBITDA Margin (Avg.)
-
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 60 | 59 | 59 | 60 | 60 | 59 | 60 | 60 | 60 | 60 | 58 | 22 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4 | 22 | 4 | 4 | 5 | 5 | 6 | 1 | 0 | 0 | 1 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 8 | 54 | 54 | 53 | 52 | 52 | 54 | 46 | 46 | 42 | 0 |
| Other Assets | 60 | 51 | 5 | 6 | 7 | 7 | 7 | 6 | 14 | 14 | 16 | 0 |
| Total Equity & Liabilities | 60 | 59 | 59 | 60 | 60 | 59 | 60 | 60 | 60 | 60 | 58 | 22 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Non Current Liabilities | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 21 |
| Total Equity | 59 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 57 | 57 | 56 | 0 |
| Reserve & Surplus | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 3 | 2 | 2 | 1 | -55 |
| Share Capital | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 55 | 55 | 55 | 55 | 55 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 21 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Investing Activities | 10 | 11 | -11 | -0 | 1 | 1 | 0 | -5 | -1 | 0 | 3 |
| Operating Activities | 8 | -11 | 11 | -1 | -1 | 0 | -0 | 5 | -0 | -0 | -2 |
| Financing Activities | 2 | 0 | 0 | 1 | 0 | -1 | 0 | -0 | 1 | 0 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Jan 2021 | Mar 2022 | Apr 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 9.66 % | 9.50 % | 14.45 % | 20.70 % | 20.70 % | 75.59 % | 75.26 % | 75.88 % | 82.77 % | 85.57 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % | 85.56 % |
| Others | 90.34 % | 90.50 % | 85.55 % | 79.30 % | 79.30 % | 24.41 % | 24.74 % | 24.12 % | 17.23 % | 14.43 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % | 14.44 % |
| No of Share Holders | 0 | 549 | 781 | 981 | 7,702 | 7,702 | 88,456 | 93,638 | 1,05,508 | 1,12,405 | 1,16,977 | 1,16,971 | 1,16,965 | 1,16,971 | 1,16,926 | 1,16,901 | 1,17,397 | 1,17,101 | 1,17,105 | 1,17,098 | 1,17,101 | 1,17,101 | 1,17,101 | 1,17,101 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Aug 2021 |  Change Of Name | NA | 23 Aug 2021 | 0.25 | 0.25 |
| 08 Apr 2022 |  Bonus | 1:10 | 07 Apr 2022 | 1.13 | 1.48 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 1.16 | 1.14 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 1.12 | 1.16 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 1.05 | 1.03 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 0.86 | 0.91 |
| 23 Jul 2025 | Quarterly Result Announcement | NA | 23 Jul 2025 | 0.88 | 0.86 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 0.78 | 0.77 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 0.63 | 0.64 |
| 14 Feb 2026 | Quarterly Result Announcement | NA | 14 Feb 2026 | 0.61 | 0.59 |
| 27 May 2026 | Quarterly Result Announcement | NA | 27 May 2026 | 0.56 | 0.55 |
| 13 Aug 2026 | Quarterly Result Announcement | NA | 13 Aug 2026 | 0.47 | 0.48 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
8 days agoUndertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On June 30Th 2026.9 days ago
9 days agoSubmission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th 2026 And Along With Limited Review Report Thereon.9 days ago
9 days agoBoard Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday 13Th August 2026 At Pursuant To Regulation 30 Of
The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Change in Registered Office AddressAug 11, 2026
Aug 11, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June 2026.Aug 08, 2026
Aug 08, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Jul 13, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Submission Of Audited Financials Results Of Jhonson Pharmacare Ltd. For The Quarter And Year Ended On March 31St 2026Jun 19, 2026
Jun 19, 2026Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJun 12, 2026
Jun 12, 2026Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The
SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
May 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2026
May 28, 2026Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015.May 27, 2026
May 27, 2026Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter And Financial Year Ended On March 31St 2026.May 27, 2026
May 27, 2026Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter
And Financial Year Ended On March 31St 2026 Along With Audited Report ThereonMay 27, 2026
May 27, 2026Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter
And Financial Year Ended On March 31St 2026 Along With Audited Report ThereonMay 27, 2026
May 27, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The
SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 27, 2026
May 27, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Audited Financial Results For The Quarter & Year Ended On 31St March 2026.May 22, 2026
May 22, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2May 09, 2026
May 09, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 17, 2026
Apr 17, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 17, 2026
Apr 17, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI
(Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 17, 2026
Apr 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Apr 13, 2026Closure of Trading WindowMar 21, 2026
Mar 21, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sFeb 17, 2026
Feb 17, 2026Board Meeting Outcome for Revised Outcome Of Meeting Of Board Of Directors Held On Friday 13Th
February 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015(SEBI LODR Regulation).Feb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Feb 16, 2026Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR)
Regulations 2015 For The Quarter Ended On 31St December 2025.Feb 14, 2026
Feb 14, 2026Submission Of Unaudited (Standalone) Financial Results Of (Johnson Pharmacare
Limited) For The Quarter Ended On 31St December 2025 Along With Limited Review
Report Thereon.Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 14Th February 2026 As Per
Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
2015.Feb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sFeb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Friday 13Th February 2026
At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure
Requirements) Regulations 2015.Feb 13, 2026
Feb 13, 2026Board Meeting Intimation for Intimation For The Postponement Of Board MeetingFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 09, 2026
Feb 09, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI (Listing
Obligations And Disclosure Requirements) Regulations 2015.Feb 09, 2026
Feb 09, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited Financial
Results For The Quarter Ended On 31St December 2025.Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressFeb 02, 2026
Feb 02, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI (Listing
Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI LODR
Regulations)Feb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJan 31, 2026
Jan 31, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI
(Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJan 24, 2026
Jan 24, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 24, 2026
Jan 24, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Pursuant To Regulation 30 Of The SEBI (Listing
Obligations And Disclosure Requirements) Regulations 2015.Jan 24, 2026
Jan 24, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJan 15, 2026
Jan 15, 2026Technical Indicators
RSI(14)
Neutral 47.80
ATR(14)
Less Volatile 0.01
STOCH(9,6)
Neutral 50.00
STOCH RSI(14)
Neutral 67.73
MACD(12,26)
Bullish 0.00
ADX(14)
Very Strong Trend 56.61
UO(9)
Bearish 48.78
ROC(12)
Downtrend And Accelerating -2.08
WillR(14)
Neutral -33.33
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
